RBL2 and cancer: We then analysed the expression of WNT ligands (WNT7B, WNT9A, WNT3A, WNT4) in RBL2-LOH cancer cell lines (HCC1500 and Cal-51) and in RBL2-wildtype cancers (MCF7 and T47D).